Almirall, S.A. (OTCMKTS:LBTSF – Get Free Report) was down 3.5% during mid-day trading on Friday . The company traded as low as $9.17 and last traded at $9.17. Approximately 312 shares were traded during trading, an increase of 56% from the average daily volume of 200 shares. The stock had previously closed at $9.51.
Almirall Trading Down 3.5 %
The company has a 50-day moving average price of $9.51 and a 200-day moving average price of $9.51.
About Almirall
Almirall, SA, a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.
Read More
- Five stocks we like better than Almirall
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Disney’s Magic Strategy: Reinventing the House of Mouse
- 3 REITs to Buy and Hold for the Long Term
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- What Investors Need to Know About Upcoming IPOs
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Almirall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almirall and related companies with MarketBeat.com's FREE daily email newsletter.
